Odonate Therapeutics OverviewOdonate Therapeutics Net Income
Profitability analysis for ODT.
Quarterly Net Income
-$14.00M
↑ 54.07% YoY
As of Sep 2021
Annual Net Income (TTM)
-$102.07M
↑ 16.28% YoY
Trailing 12 months ending Sep 2021
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...